Alex Hinga

Alex Hinga holds an MSc in Public Health from UWE Bristol and a BSc in Medical Laboratory Science from Kenyatta University. After his undergraduate studies, he was awarded a national research internship by CNHR Kenya which he successfully completed in 2011. This internship enhanced his research skills and strengthened his resolve to pursue a career in research for health. In 2012, Hinga won an international scholarship to study public health. While working on his MSc thesis at Public Health England, he developed a strong interest in multidisciplinary public health research.

Hinga is currently investigating ethical issues for health and demographic surveillance systems (HDSS) in sub-Saharan Africa. His PhD study has the potential to deepen our understanding and influence policy on data sharing, community engagement and consent in HDSS and other population-based surveillance systems. Overall, Hinga has research interests in critical bioethics, public policy analysis and evaluation of complex social interventions

Michelle Muthui

My research focus lies in identifying malaria parasite targets on the forms of the parasite responsible for human to mosquito transmission which if blocked by antibodies or drugs would inhibit the development of the parasite within the mosquito. These targets can then be used to aid the design of transmission-blocking vaccines which unlike conventional vaccines that protect against disease, prevent the transmission of malaria. I have previously worked on assessing the relationship between a parasite variant surface antigen (PfEMP1) and the different clinical manifestations of malaria using molecular assays in a bid to identify a subset of these antigens with a role in severe malaria. My background training is in biochemistry and molecular genetics which has not only helped me in my chosen field of study but also inspired me to delve deeper into parasite genetics. Aside from research, I like to participate in student mentorship programmes.

Publications:

1. Serological conservation of parasite-infected erythrocytes predicts PfEMP1 antigen expression but not childhood malaria severity, Warimwe GM, Abdi AI, Muthui M, Fegan G, Musyoki JN, Marsh K, et al. | Infect Immun. 2016; doi:10.1128/IAI.00772-15.
2. Global selection of Plasmodium falciparum virulence antigen expression by host antibodies., Abdi AI, Warimwe GM, Muthui MK, Kivisi CA, Kiragu EW, Fegan GW, et al. | Sci Rep. 2016;6: 19882. doi:10.1038/srep19882.
3. Differential Plasmodium falciparum surface antigen expression among children with Malarial Retinopathy, Abdi AI, Kariuki SM, Muthui MK, Kivisi C a., Fegan G, Gitau E, et al. | Sci Rep. Nature Publishing Group; 2015;5: 18034. doi:10.1038/srep18034.
4. Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection, Hodgson SH, Juma E, Salim A, Magiri C, Kimani D, Njenga D, et al. | Front Microbiol. 2014;5: 1–10. doi:10.3389/fmicb.2014.00686.
5. Measuring Soluble ICAM-1 in African Populations, Abdi AI, Muthui M, Kiragu E, Bull PC | PLoS One. 2014;9: e108956. doi:10.1371/journal.pone.0108956.
6. Plasmodium falciparum antigenic variation: relationships between widespread endothelial activation, parasite PfEMP1 expression and severe malaria. Abdi AI, Fegan G, Muthui M, Kiragu E, Musyoki JN, Opiyo M, et al. | BMC Infect Dis. BMC Infectious Diseases; 2014;14: 170. doi:10.1186/1471-2334-14-170.